echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Ann Rheum Dis: Comparison of the efficacy of tofacitinib and baritinib in the treatment of rheumatoid arthritis

    Ann Rheum Dis: Comparison of the efficacy of tofacitinib and baritinib in the treatment of rheumatoid arthritis

    • Last Update: 2021-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In clinical practice, the difference in the efficacy of each Janus kinase (JAK) inhibitor in the treatment of rheumatoid arthritis (RA) is not clear


    In clinical practice, the difference in the efficacy of each Janus kinase (JAK) inhibitor in the treatment of rheumatoid arthritis (RA) is not clear



    The study compared the effects of TOFA (n=156) and BARI (n=138) on patients with RA


    After adjustment, there was no significant difference in patient characteristics between the TOFA group and the BARI group


    After adjustment, there was no significant difference in patient characteristics between the TOFA group and the BARI group




    It can be seen that BARI has better clinical efficacy than TOFA, and the safety of the two is equivalent


     

    Original source:

    Original source: Original source:

    Yusuke Miyazaki.


    Yusuke Miyazaki.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.